ArthritisNCT04913974
Univation X Partial Knee Study
An observational study of Arthritis, run by Golden Jubilee National Hospital at 1 site in United Kingdom.
Trial summary
The objective of this study is to investigate the functional and clinical outcome after medial unicompartmental knee replacement using the Aesculap AG Univation X knee prosthesis compared to pre-operative data and a healthy control group. Read more about this study
- Who is it for?
- Ages 45 to 75 years
- Conditions the study is for
- Arthritis
- What is being tested?
- Uni-condylar knee arthroplasty
- Type of treatment
- Surgery or procedure
- How many people
- 0 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- Feb 2020to Nov 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Male and female participants aged between 45 and 75 inclusive under the care of one of the study surgeons who have been listed for uni-condylar knee replacement surgery. They must live locally enough to be intending returning to the hospital for follow-ups rather than opting to be followed-up locally. They should have a BMI of under 40 otherwise skin artifacts would be an issue for the accuracy of the biomechanical analysis. They must have had no previous lower limb arthroplasty in the previous 12 months or conditions which could influence their mobility other than the condition for which they are having arthroplasty for.
Who may be able to join
- Patients having medial uni-compartmental knee arthroplasty Functionally intact anterior cruciate ligament Able to give informed consent Able to return to GJNH for follow-up BMI under 40
Who cannot join
- Inflammatory joint disease e.g. rheumatoid arthritis Previous hip procedure in the last twelve months Previous knee surgery other than arthroscopy and medial menisectomy Previous ankle surgery Symptomatic foot, hip or spinal pathology Any medical condition limiting normal ambulation e.g. stroke, Charcot-Marie-Tooth disease, severe lymphedema, advanced cardiac disease
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
Golden Jubilee National Hospital
Clydebank, West Dunbartonshire, G81 4dy
About this study
Official title: Univation X: A Functional and Clinical Outcomes Study of a Partial Knee Replacement
The objective of this study is to investigate the functional and clinical outcome after medial unicompartmental knee replacement using the Aesculap AG Univation X knee prosthesis compared to pre-operative data and a healthy control group.
Read the detailed description
All potential medial uni-compartmental knee arthroplasty patients from consultant orthopaedic surgeons at the Golden Jubilee National Hospital (GJNH) will be screened in relation to the inclusion/exclusion criteria. Invitation letters and participant information sheets (PIS) will be sent out to suitable patients who have been referred to the GJNH for a knee replacement (allocated patients) prior to their pre-operative consultation with their surgeon. They will be approached at their consultation visit to seek consent to take part in the study. Patients who have been referred to the GJNH for assessment for a knee replacement (see and treat patients) will be approached only if they are deemed eligible for uni-compartmental knee replacement by their consultant, and will be given a copy of the participant information sheet along with the invitation letter. They will be approached for consent to take part in the study at their pre-operative assessment. All patients will be contacted by telephone around a day after receiving the participant information sheet to ask for verbal consent. This is necessary to arrange the pre-operative CT scans and biomechanical testing. All patients will be given the opportunity to ask questions about the study before signing the consent form. Consent will be taken by the chief investigator or their delegate, using a signed form.
Thirty patients will be recruited to the study. They will have their surgery performed by one of the participating consultants using the study implant, the Univation X unicondylar knee system manufactured by Aesculap AG.
Participants will receive their standard in-patient care and rehabilitation. Standard hospital care for knee arthroplasty patients is for them to return to the hospital for a post-operative review at 6 weeks and then 1 year after operation. Study participants will also be asked to attend the GJNH for one additional research specific appointment at two years post-operatively.
During the standard care appointments, patients will be reviewed by a member of the arthroplasty team who will collect routine data on the clinical and functional outcomes and implant stability. These data include the Oxford Knee Score (OKS), EURO Quality of life questionnaire (EQ-5D 5L), patient satisfaction and standard radiographic assessment of the implant.
Detailed radiographic analysis will be carried out on radiographs collected as standard practice and computed tomography (CT) scans taken specifically for the study. Radiographs will be taken pre-operatively, post-operation at day one (standard), 1 year (standard) and the 2 year (study) time points. Patients will have a CT scan pre-operatively and 6 weeks post-operatively. The post-operative scan will be performed instead of the radiographs usually take at this time point. The pre-operative scan will be performed in addition to the pre-operative radiographs.
Study participants will also have two sessions of specialised functional assessment using clinical movement analysis before surgery and 1 year after surgery during their standard pre- and post-operative visits. Biomechanical movement analysis will be carried out in an on-site movement analysis laboratory. Study participants will be required to wear suitable clothing (e.g. tee shirt and shorts) and be barefoot. A number of reflective markers will be attached to specific locations on the body (using suitable double sided tape) which will be tracked by a number of infrared cameras. Participants will be asked to perform the following tasks; level walking, incline walking, decline walking, stand-to-sit-to-stand, step ascent and descent and single leg balance. Each task will be performed at least three times to enable the collection of three good sets of data. In addition, the two stepping tasks will be repeated for each limb. The single leg balance will be performed once for each leg and data will be collected for 30 seconds per limb. A motion capture system will collect limb and torso movements during the task performances while force plates will collect ground reaction forces.
After the two year follow-up appointment the patients involvement in the study will be complete.
- Conditions
- Arthritis
- Being tested
- Uni-condylar knee arthroplasty
- Keywords
- unicondylar knee replacement, uni-compartmental knee replacement, knee arthroplasty, gait, motion analysis
- Medical subject headings
- Arthritis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Uni-condylar knee arthroplastyProcedure or surgery
Also called uni-condylar knee replacement
Surgical replacement of medial compartment of arthritic knee with an implant
| Study group | Role | What they receive |
|---|---|---|
| Uni-condylar knee arthroplasty | A cohort of patients who will undergo uni-condylar knee replacement surgery with the Univation X system and have biomechanical anaylsis Receives: Procedure: Uni-condylar knee arthroplasty |
What is being measured
The primary outcome is the main question the study is designed to answer.
Knee joint angle during step descent
Knee angles collected using clinical movement analysis
Measured: up to 1 year
Secondary outcomes (7)
Oxford Knee Score
Patient-reported knee pain and function
Measured: Pre-operatively, 6 weeks, 1 year and 2 years post-op
EQ5D-5L
Patient-reported quality of life
Measured: Pre-operatively, 6 weeks, 1 year and 2 years post-op
Patient satisfaction
Patient-reported satisfaction of the knee using a five point Likert scale
Measured: 6 weeks, 1 year and 2 years post-op
Implant survivorship
Percentage of implants still in situ over time.
Measured: 2 years
Peri-prosthetic lucency
Radiolucent lines (>2mm wide) around the component which may indicate component loosening
Measured: 6 weeks, 1 year and 2 years post-op
Component position
Migration of the component over time measured from CT scans
Measured: 6 weeks, 1 year and 2 years post-op
Complications
Any post-operative complications as a result of surgery, e.g. infection, revision, aseptic loosening.
Measured: 6 weeks, 1 year and 2 years post-op
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Jun 2021
- Study startFeb 2020 (estimated)
- Primary completionJul 2023 (estimated)
- Study completionNov 2023 (estimated)
Why it stopped: Surgeons unhappy with the outcome from pre-study implants
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ArthritisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Golden Jubilee National Hospital
- Sponsor type
- Other government
- Collaborators
- Aesculap AG
- Responsible party
- Sponsor
- Investigators
- Nicholas Ohly, MBBS, Principal investigator, Golden Jubilee National Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04913974
- Sponsor's protocol ID
- Ortho 17-06
- Status last verified
- Jun 2021
- First submitted
- 17 Jul 2019
- Last updated
- 4 Jun 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Jun 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Univation X: A Functional and Clinical Outcomes Study of a Partial Knee Replacement
- ClinicalTrials.gov ID
- NCT04913974
- Acronym / sponsor ID
- Ortho 17-06
- Conditions
- Arthritis
- Keywords
- unicondylar knee replacement, uni-compartmental knee replacement, knee arthroplasty, gait, motion analysis
- Study type
- Observational
- Recruitment status
- WithdrawnReason stopped: Surgeons unhappy with the outcome from pre-study implants
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Golden Jubilee National HospitalOther government
- Collaborators
- Aesculap AG
- Study start
- Feb 2020 (estimated)
- Primary completion
- Jul 2023 (estimated)
- Study completion
- Nov 2023 (estimated)
- First posted
- 4 Jun 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of this study is to investigate the functional and clinical outcome after medial unicompartmental knee replacement using the Aesculap AG Univation X knee prosthesis compared to pre-operative data and a healthy control group.
Detailed description
All potential medial uni-compartmental knee arthroplasty patients from consultant orthopaedic surgeons at the Golden Jubilee National Hospital (GJNH) will be screened in relation to the inclusion/exclusion criteria. Invitation letters and participant information sheets (PIS) will be sent out to suitable patients who have been referred to the GJNH for a knee replacement (allocated patients) prior to their pre-operative consultation with their surgeon. They will be approached at their consultation visit to seek consent to take part in the study. Patients who have been referred to the GJNH for assessment for a knee replacement (see and treat patients) will be approached only if they are deemed eligible for uni-compartmental knee replacement by their consultant, and will be given a copy of the participant information sheet along with the invitation letter. They will be approached for consent to take part in the study at their pre-operative assessment. All patients will be contacted by telephone around a day after receiving the participant information sheet to ask for verbal consent. This is necessary to arrange the pre-operative CT scans and biomechanical testing. All patients will be given the opportunity to ask questions about the study before signing the consent form. Consent will be taken by the chief investigator or their delegate, using a signed form.
Thirty patients will be recruited to the study. They will have their surgery performed by one of the participating consultants using the study implant, the Univation X unicondylar knee system manufactured by Aesculap AG.
Participants will receive their standard in-patient care and rehabilitation. Standard hospital care for knee arthroplasty patients is for them to return to the hospital for a post-operative review at 6 weeks and then 1 year after operation. Study participants will also be asked to attend the GJNH for one additional research specific appointment at two years post-operatively.
During the standard care appointments, patients will be reviewed by a member of the arthroplasty team who will collect routine data on the clinical and functional outcomes and implant stability. These data include the Oxford Knee Score (OKS), EURO Quality of life questionnaire (EQ-5D 5L), patient satisfaction and standard radiographic assessment of the implant.
Detailed radiographic analysis will be carried out on radiographs collected as standard practice and computed tomography (CT) scans taken specifically for the study. Radiographs will be taken pre-operatively, post-operation at day one (standard), 1 year (standard) and the 2 year (study) time points. Patients will have a CT scan pre-operatively and 6 weeks post-operatively. The post-operative scan will be performed instead of the radiographs usually take at this time point. The pre-operative scan will be performed in addition to the pre-operative radiographs.
Study participants will also have two sessions of specialised functional assessment using clinical movement analysis before surgery and 1 year after surgery during their standard pre- and post-operative visits. Biomechanical movement analysis will be carried out in an on-site movement analysis laboratory. Study participants will be required to wear suitable clothing (e.g. tee shirt and shorts) and be barefoot. A number of reflective markers will be attached to specific locations on the body (using suitable double sided tape) which will be tracked by a number of infrared cameras. Participants will be asked to perform the following tasks; level walking, incline walking, decline walking, stand-to-sit-to-stand, step ascent and descent and single leg balance. Each task will be performed at least three times to enable the collection of three good sets of data. In addition, the two stepping tasks will be repeated for each limb. The single leg balance will be performed once for each leg and data will be collected for 30 seconds per limb. A motion capture system will collect limb and torso movements during the task performances while force plates will collect ground reaction forces.
After the two year follow-up appointment the patients involvement in the study will be complete.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Uni-condylar knee arthroplasty | – | Procedure: Uni-condylar knee arthroplastyA cohort of patients who will undergo uni-condylar knee replacement surgery with the Univation X system and have biomechanical anaylsis |
Who may qualify
- Ages
- 45 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Male and female participants aged between 45 and 75 inclusive under the care of one of the study surgeons who have been listed for uni-condylar knee replacement surgery. They must live locally enough to be intending returning to the hospital for follow-ups rather than opting to be followed-up locally. They should have a BMI of under 40 otherwise skin artifacts would be an issue for the accuracy of the biomechanical analysis. They must have had no previous lower limb arthroplasty in the previous 12 months or conditions which could influence their mobility other than the condition for which they are having arthroplasty for.
Key inclusion criteria (1 listed)
- Patients having medial uni-compartmental knee arthroplasty Functionally intact anterior cruciate ligament Able to give informed consent Able to return to GJNH for follow-up BMI under 40
Key exclusion criteria (1 listed)
- Inflammatory joint disease e.g. rheumatoid arthritis Previous hip procedure in the last twelve months Previous knee surgery other than arthroscopy and medial menisectomy Previous ankle surgery Symptomatic foot, hip or spinal pathology Any medical condition limiting normal ambulation e.g. stroke, Charcot-Marie-Tooth disease, severe lymphedema, advanced cardiac disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Uni-condylar knee arthroplastyAlso: uni-condylar knee replacementSurgical replacement of medial compartment of arthritic knee with an implant | Procedure or surgery | Uni-condylar knee arthroplasty |
Primary outcome
Knee joint angle during step descent
Time frame: up to 1 year
Knee angles collected using clinical movement analysis
7 secondary outcomes
Oxford Knee Score
Time frame: Pre-operatively, 6 weeks, 1 year and 2 years post-op
EQ5D-5L
Time frame: Pre-operatively, 6 weeks, 1 year and 2 years post-op
Patient satisfaction
Time frame: 6 weeks, 1 year and 2 years post-op
Implant survivorship
Time frame: 2 years
Peri-prosthetic lucency
Time frame: 6 weeks, 1 year and 2 years post-op
Component position
Time frame: 6 weeks, 1 year and 2 years post-op
Complications
Time frame: 6 weeks, 1 year and 2 years post-op
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Jun 2021.
- Individual participant dataSharing planned: No
Related trials for Arthritis
Active, not recruitingPhase 1
Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis
Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA)
Recruiting
Oral Nutritional Optimization in Total Joint Arthroplasty
Osteoarthritis
Recruiting
Shock Waves in Knee Arthritis
Arthritis of Knee
Not yet recruiting
Opioid Reduction and Enhanced Recovery in Orthopaedic Surgery (OREOS)-Knee
Knee Arthroplasty, Total, Partial Knee Arthroplasty
Recruiting
Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy
Facet Joint Arthropathy, Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Nicholas Ohly, MBBS principal investigator
Golden Jubilee National Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Arthritis, run by Golden Jubilee National Hospital at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 4 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Knee joint angle during step descent (time frame: up to 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2021.